[1]
S. K. Verma, S. Bala, and Y. Singh, “Assessment of levetiracetam and valproic acid as monotherapy for quality of life in partial epilepsy patients”, Int J Basic Clin Pharmacol, vol. 8, no. 11, pp. 2434–2439, Oct. 2019.